Showing 141 - 160 results of 260,527 for search '(( 0 ((0 decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (mean decrease)) ))', query time: 0.48s Refine Results
  1. 141

    Long-term treatment with rapamycin results in decrease in cellular immune factors. by Zhenya Lu (780517)

    Published 2015
    “…No obvious change was noted among different groups in Il-1β both in brain and blood (A,B). IL-2 was decreased with 1.0 and 3.0 mg/kg rapamycin treatment both in brain and blood (C, D). …”
  2. 142
  3. 143
  4. 144
  5. 145

    S1 Data - by Jan Willem Koten (17743224)

    Published 2024
    Subjects:
  6. 146
  7. 147

    FTY720 decreased viability, proliferation, and motility and induced apoptosis in human hepatoblastoma cells. by Laura L. Stafman (6577184)

    Published 2019
    “…<p>(A) Following 24 hours of treatment with FTY720, the viability of HuH6 cells measured using the alamarBlue cell viability assay was significantly decreased (LD<sub>50</sub> = 8.4 μM, p ≤ 0.05). …”
  8. 148
  9. 149
  10. 150
  11. 151

    Decreased NR1 and NR2A protein expression in 21-day group. by Chenxia Han (4020017)

    Published 2017
    “…<p>All data are presented as the mean ± SEM (n = 8); **refers to p<0.01 vs. control group. …”
  12. 152
  13. 153
  14. 154
  15. 155
  16. 156
  17. 157

    Fig 3 - by Hiroyuki Matsuta (13250169)

    Published 2022
    Subjects:
  18. 158

    DataSheet_1_Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients.docx by Zijing Ran (11429935)

    Published 2021
    “…</p>Results<p>ULT resulted in a mean (standard deviation) decrease in SU level (464.22 ± 110.21 μmol/L at baseline, 360.93 ± 91.66 μmol/L at the final visit, p <0.001) accompanied by a decrease in median (interquartile range) VFA [97.30 (81.15–118.55) at baseline, 90.90 (75.85–110.05) at the final visit, p < 0.001]. …”
  19. 159
  20. 160